Ocean BiomedicalOCEA

13F holders, Q3 2024 (September 30)
20holders −15
3new positions
18sold out
2famous investors
$0.97avg. 13F price*

At the end of Q3 2024, 20 institutions reported holding Ocean Biomedical Inc. (OCEA) in their 13F filings, down 15 from Q2 2024. 3 opened new positions and 18 sold out. The largest holders were Polar Asset Management Partners Inc. ($2.6M), Vanguard Group Inc. ($398K) and Geode Capital Management, LLC ($138K). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Ocean Biomedical Inc.
CUSIP
67644C104
Latest filing quarter
Q2 2026

History

Number of 13F holders

01020304050 Q1 2024: 43Q1 2024Q2 2024: 35Q2 2024Q3 2024: 20Q3 2024Q4 2024: 21Q4 2024Q1 2025: 23Q1 2025Q2 2025: 6Q2 2025Q3 2025: 1Q3 2025Q4 2025: 1Q4 2025Q1 2026: 1Q1 2026Q2 2026: 1Q2 2026

Total Exit/New Position Q2 2024 → Q3 2024

InstitutionsTotal Value
New Positions3$52K
Exits18$320K

All 13F filers, Q2 2024 → Q3 2024: 53,539 shares bought and 389,790 shares sold, net −336,251 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 20 holders

Polar Asset Management Partners Inc. 0.09% No change 2,688,193 $2.6M
Vanguard Group Inc. 0.00% No change 406,529 $398K
Geode Capital Management, LLC 0.00% Reduce -1.3% 140,991 $138K
Millennium Management 0.00% Reduce -24.1% 127,562 $125K
BlackRock, Inc. 0.00% — 60,751 $60K
Citadel Advisors 0.00% New 32,908 $32K
State Street Corp. 0.00% No change 32,800 $32K
Northern Trust Corp. 0.00% Reduce -65.8% 26,775 $26K
Bank of Montreal 0.00% No change 20,000 $20K
XTX Topco Ltd 0.00% New 18,562 $18K
ACT Advisors, LLC. 0.01% Add +0.4% 16,701 $16K
Tower Research Capital LLC (TRC) 0.00% Reduce -55.0% 4,583 $4K
FMR LLC 0.00% Reduce -70.4% 2,439 $2K
Nordwand Advisors, LLC 0.00% New 2,000 $2K
Citigroup Inc. 0.00% Reduce -74.4% 791 $775
Morgan Stanley 0.00% Reduce -97.5% 399 $391
Bank of America Corp. 0.00% Reduce -18.8% 229 $224
JPMorgan Chase & Co. 0.00% Reduce -88.1% 209 $205
UBS Group AG 0.00% Reduce -94.2% 152 $149
FNY Investment Advisers, LLC 0.00% Reduce -25.0% 600 $0

"% of holder's portfolio" is OCEA's weight in each manager's 13F, not the share of Ocean Biomedical Inc. the manager owns.